Year archive

Ondine Biomedical Inc. — 2022 filings

All 33 regulatory filings released by Ondine Biomedical Inc. (OBI) in 2022, sourced directly from the official regulator.

33 Filings

2022 Period

2022 filings (33)

Filing	Released	Lang
Appointment of Nominated Adviser Regulatory Filings	2022-12-30	English
Steriwave receives regulatory approval in Mexico Regulatory Filings	2022-12-12	English
Ondine receives funding for meat photodisinfection Regulatory Filings	2022-12-05	English
Ondine receives funding for meat photodisinfection Regulatory Filings	2022-12-02	English
Ondine reports full results from Phase 2 trial Regulatory Filings	2022-12-02	English
Ondine appoints Spanish distributer for Steriwave Regulatory Filings	2022-11-21	English
Ondine cuts COVID-19 rate in food processing plant Regulatory Filings	2022-11-07	English
PDMR Dealing Director's Dealing	2022-11-04	English
Ondine CTO receives Lifetime Achievement Award Regulatory Filings	2022-10-31	English
PDMR Dealing Director's Dealing	2022-10-28	English
Ondine presents new efficacy data against MRSA Regulatory Filings	2022-10-19	English
Steriwave™ cuts SSI risk by 47% at major hospital Regulatory Filings	2022-10-19	English
Investor Presentation Investor Presentation	2022-10-11	English
Interim results for the six months to 30 June 2022 Interim / Quarterly Report H1 2022	2022-09-27	English
The Ottawa Hospital pilots nasal disinfection Regulatory Filings	2022-09-23	English
New research presented on photodisinfection Regulatory Filings	2022-09-20	English
Ondine’s photodisinfection kills ESKAPE pathogens Regulatory Filings	2022-09-07	English
Ondine reports successful US Phase 2 trial data Regulatory Filings	2022-09-06	English
Nature reports Ondine therapy suppresses COVID-19 Regulatory Filings	2022-08-31	English
Ondine appoints RBC and Singer as joint brokers Regulatory Filings	2022-08-16	English
Ondine completes US Phase II trial recruitment Regulatory Filings	2022-08-08	English
Completion of Nominated Adviser due diligence Regulatory Filings	2022-07-26	English
Issue of Equity Share Issue/Capital Change	2022-07-22	English
Ondine completes successful SARS-CoV-2 trial Regulatory Filings	2022-07-19	English
Result of AGM Declaration of Voting Results & Voting Rights Announcements	2022-06-08	English
Posting of annual report Report Publication Announcement	2022-06-07	English
Full Year Results to 31 December 2021 Earnings Release FY 2021	2022-05-19	English
Notice of AGM AGM Information	2022-05-17	English
WHO calls for better infection prevention Regulatory Filings	2022-05-10	English
Appointment of Nominated Adviser Regulatory Filings	2022-04-27	English
Photodisinfection effective against SARS-CoV-2 Regulatory Filings	2022-04-05	English
Grant of Options and PDMR Dealing Director's Dealing	2022-02-21	English
Ondine treats first patients in Phase 2 FDA trial Regulatory Filings	2022-02-07	English